Hallal David
SEC CIK 1457477 · EDGAR
BoughtSold
Most active insiders at SRRK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | AKKARAJU SRINIVAS | Dir | $19.99M | — |
| 2 | Qatanani Mo | CSO | — | $8.60M |
| 3 | Hallal David | CEO, Dir | — | $3.97M |
| 4 | Vaishnaw Akshay | Pres of R, D, Dir | — | $1.48M |
| 5 | Sinha Vikas | CFO | — | $1.23M |
| 6 | Woods Keith | COO | — | $1.22M |
| 7 | Ho Junlin | GC | — | $802.3K |
| 8 | Parlavecchio Caryn | CHRO | — | $714.0K |
| 9 | Marantz Jing L. | Chief Medical Off | — | $451.3K |
| 10 | Peng Katie | Dir | — | $337.8K |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-23 16:36 | 2026-09-21 | SRRK | Scholar Rock Holding Corp | Hallal David | CEO, Dir | G - Gift | $0.00 | -36.7K | 1.60M | -2% | $0 | |
| 2026-04-20 18:08 | 2026-04-16 | SRRK | Scholar Rock Holding Corp | Hallal David | CEO, Dir | S - Sale | $49.57 | -30.6K | 1.64M | -2% | -$1.52M | |
| 2026-02-11 | 2026-02-09 | SRRK | Scholar Rock Holding Corp | Hallal David | CEO, Dir | A - Grant | $0.00 | +128.0K | 1.67M | +8% | $0 | |
| 2026-01-15 | 2026-01-13 | SRRK | Scholar Rock Holding Corp | Hallal David | CEO, Dir | S - Sale | $42.70 | -57.5K | 1.54M | -4% | -$2.45M | |
| 2025-10-09 | 2025-10-08 | SRRK | Scholar Rock Holding Corp | Hallal David | CEO, Dir | G - Gift | $0.00 | -205.0K | 1.60M | -11% | $0 | |
| M | 2025-04-29 | 2025-04-27 | SRRK | Scholar Rock Holding Corp | Hallal David | CEO, Dir | A - Grant | $0.00 | +1.50M | 554.1K | New | $0 |
| D | 2024-07-01 | 2024-06-27 | SRRK | Scholar Rock Holding Corp | Hallal David | Dir | A - Grant | $0.00 | +13.5K | 304.1K | +5% | $0 |
| 2024-06-14 | 2024-06-12 | SEER | Seer, Inc. | Hallal David | Dir | A - Grant | $0.00 | +58.2K | 355.1K | +20% | $0 | |
| 2024-06-07 | 2024-06-06 | KLRS | Kalaris Therapeutics, Inc. | Hallal David | Dir, 10% | A - Grant | $0.00 | +35.0K | 2.14M | +2% | $0 | |
| D | 2023-06-16 | 2023-06-14 | SEER | Seer, Inc. | Hallal David | Dir | A - Grant | $0.00 | +23.4K | 296.9K | +9% | $0 |
| 2023-05-12 | 2023-05-11 | KLRS | Kalaris Therapeutics, Inc. | Hallal David | Dir, 10% | A - Grant | $0.00 | +35.0K | 2.11M | +2% | $0 | |
| I | 2022-10-21 | 2022-10-19 | KLRS | Kalaris Therapeutics, Inc. | Hallal David | Dir, 10% | S - Sale | $8.45 | -600.0K | 138.2K | -81% | -$5.07M |
| I | 2022-09-30 | 2022-09-29 | KLRS | Kalaris Therapeutics, Inc. | Hallal David | Dir, 10% | S - Sale | $7.35 | -400.0K | 721.0K | -36% | -$2.94M |
| I | 2022-08-01 | 2022-07-28 | KLRS | Kalaris Therapeutics, Inc. | Hallal David | Dir, 10% | A - Grant | $4.61 | +3.25M | 16.67M | +24% | +$15.00M |
| 2022-07-21 | 2022-07-21 | KLRS | Kalaris Therapeutics, Inc. | Hallal David | Dir, 10% | S - Sale | $5.33 | -4,227 | 2.07M | -0.2% | -$22.5K | |
| D | 2022-06-17 | 2022-06-15 | SEER | Seer, Inc. | Hallal David | Dir | A - Grant | $0.00 | +9,945 | 273.5K | +4% | $0 |
| 2022-06-06 | 2022-06-03 | KLRS | Kalaris Therapeutics, Inc. | Hallal David | Dir, 10% | S - Sale | $3.67 | -65.7K | 2.08M | -3% | -$241.2K | |
| 2022-04-22 | 2022-04-21 | KLRS | Kalaris Therapeutics, Inc. | Hallal David | Dir, 10% | S - Sale | $5.87 | -4,227 | 2.14M | -0.2% | -$24.8K | |
| M | 2022-03-11 | 2022-03-10+ | KLRS | Kalaris Therapeutics, Inc. | Hallal David | Dir, 10% | S - Sale | $7.48 | -65.7K | 2.15M | -3% | -$491.7K |
| 2022-01-25 | 2022-01-24 | KLRS | Kalaris Therapeutics, Inc. | Hallal David | Dir, 10% | S - Sale | $8.01 | -17.1K | 2.21M | -0.8% | -$137.0K |
Purchase Sale Sale after option exercise All abbreviations